文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma.

作者信息

Hirano Satoshi, Tanaka Eiichi, Tsuchikawa Takahiro, Matsumoto Joe, Kawakami Hiroshi, Nakamura Toru, Kurashima Yo, Ebihara Yuma, Shichinohe Toshiaki

机构信息

Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.

出版信息

J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):533-40. doi: 10.1002/jhbp.76. Epub 2014 Jan 27.


DOI:10.1002/jhbp.76
PMID:24464984
Abstract

Due to advances in endoscopic equipment and techniques, preoperative endoscopic biliary drainage (EBD) has been developed to serve as an alternative to percutaneous transhepatic biliary drainage (PTBD). This study sought to clarify the benefit of EBD in comparison to PTBD in patients who underwent radical resections of hilar cholangiocarcinoma. One hundred and forty-one patients underwent radical surgery for hilar cholangiocarcinoma between 2000 and 2008 were retrospectively divided into two groups based on the type of preoperative biliary drainage, PTBD (n = 67) or EBD (n = 74). We investigated if the different biliary drainage methods affected postoperative survival and mode of recurrence after median observation period of 82 months. The survival rate for patients who underwent EBD was significantly higher than those who had PTBD (P = 0.004). Multivariate analysis revealed that PTBD was one of the independent factors predictive of poor survival (hazard ratio: 2.075, P = 0.003). Patients with PTBD more frequently developed peritoneal seeding in comparison to those who underwent EBD (P = 0.0003). PTBD was the only independent factor predictive of peritoneal seeding. In conclusion, EBD might confer an improved prognosis over PTBD due to prevention of peritoneal seeding, and is recommended as the initial procedure for preoperative biliary drainage in patients with hilar cholangiocarcinoma.

摘要

相似文献

[1]
Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma.

J Hepatobiliary Pancreat Sci. 2014-8

[2]
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.

Ann Surg Oncol. 2015-12

[3]
Prognostic impact of type of preoperative biliary drainage in patients with distal cholangiocarcinoma.

Am J Surg. 2017-8

[4]
Impact of preoperative percutaneous transhepatic biliary drainage on post-operative survival in patients with distal cholangiocarcinoma.

ANZ J Surg. 2019-9

[5]
Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: a propensity score matching analysis in resectable distal cholangiocarcinoma.

J Gastroenterol. 2015-11-9

[6]
Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.

J Surg Oncol. 2018-5

[7]
A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction.

World J Surg Oncol. 2019-7-5

[8]
Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma.

J Gastrointest Surg. 2009-9-15

[9]
Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis.

J Laparoendosc Adv Surg Tech A. 2018-9

[10]
A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic versus Percutaneous Transhepatic Biliary Drainage.

Gut Liver. 2015-11-23

引用本文的文献

[1]
Perihilar cholangiocarcinoma: a surgeon's perspective.

ILIVER. 2022-4-5

[2]
Endoscopic treatment of unresectable perihilar cholangiocarcinoma: beyond biliary drainage.

Therap Adv Gastroenterol. 2025-4-14

[3]
Comparative study of therapeutic outcomes in patients who developed hepatolithiasis after hepaticojejunostomy: balloon-assisted enteroscopic approach versus percutaneous transhepatic approach.

Surg Endosc. 2025-2

[4]
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma.

World J Gastroenterol. 2024-3-7

[5]
Essential updates 2021/2022: Update in surgical strategy for perihilar cholangiocarcinoma.

Ann Gastroenterol Surg. 2023-9-8

[6]
The Short- and Long-Term Surgical Results of Consecutive Hepatopancreaticoduodenectomy for Wide-Spread Biliary Malignancy.

Ann Surg Oncol. 2024-1

[7]
Comparing the efficacy and complications of Endoscopic Biliary Drainage (EBD) and Percutaneous Transhepatic Biliary Drainage (PTBD) in patients with perihilar cholangiocarcinoma.

J Family Med Prim Care. 2022-12

[8]
Endoscopic Biliary Darinage (EBD) versus Percutaneous Transhepatic Biliary Drainage (PTBD) for biliary drainage in patients with Perihilar Cholangiocarcinoma (PCCA): A systematic review and meta-analysis.

Clinics (Sao Paulo). 2023

[9]
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.

Dig Dis Sci. 2023-4

[10]
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

Hepatobiliary Surg Nutr. 2022-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索